NCT01889095View on ClinicalTrials.gov

Biphasic Insulin Aspart Versus NPH Plus Regular Human Insulin in Type 2 Diabetic Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

August 31, 2011

Study Completion Date

July 31, 2012

Conditions
Diabetes Type 2
Interventions
DRUG

BIAsp 30

patients receiving variable doses of Insulin BIAsp 30.start with 0.2 to 0.6unit per kg

DRUG

NPH/Reg

patients receiving Variable doses Of Insulin NPH Start with 0.2 to 0.6 unit per kg

Trial Locations (1)

13145-784

Tehran University of Medical Sciences, Tehran

All Listed Sponsors
lead

Tehran University of Medical Sciences

OTHER

NCT01889095 - Biphasic Insulin Aspart Versus NPH Plus Regular Human Insulin in Type 2 Diabetic Patients | Biotech Hunter | Biotech Hunter